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ABSTRACT 
Iron oxide nanoparticles were synthesized using aqueous extracts of Syzygium aromaticum. Total phenolic content and iron oxide nanoparticles 
were found to increasing with concentration of extract and had higher antioxidant activity. The UV-Visible spectral analysis showed absorption 
peaks at 240 nm. SEM image of nanoparticles revealed that they were aggregated and had irregular shape. The signals obtained in EDAX 
spectrum imply that particles synthesized were iron oxide nanoparticles. The FT-IR spectrum revealed that nanoparticles which is capped by C-
H group of alkane. The average size of nanoparticles was 52 nm. The nanoparticles were mixed with bee venom in various ratios to enhance 
anticancer activity and were identified as 1:1. MTT assay of 1:1 volume ratio of iron oxide nanoparticles and bee venom was found to have 
cytotoxicity higher than absence of nanoparticles. It confirmed the enhancement of anticancer activity by iron oxide nanoparticles of clove 
extract. 
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In the recent years, the study of different types of cancer 
treatments is one of the important areas in modern science. 
Cancer may be caused by various factors like genetic 
problems, incorrect diet, exposing to harmful radiation etc. 
The common treatment for cancer is unfavourable because it 
causes many detrimental side effects and lately, there has 
been a growing resistance towards anticancer drugs, which 
worsens the future of cancer treatment1. Nanotechnology is 
an interesting field for the researchers. It is one of the recent 
advancement in the area of cancer research. The use of 
Nanotechnology in cancer treatment offers some exciting 
possibilities, including the possibility of destroying cancer 
tumor with minimal damage to healthy tissue and organs, as 
well as the detection and elimination of cancer cells before 
they form tumors. Many natural compounds have anti-
cancer activity are used as a drug for the cancer treatment. 
Targeting the anti-cancer compound using nanoparticles 
was a promising way to increase the treatment efficiency2.  
An extensive research has been focused on the magnetic 
nanoparticles for drug targeting. Magnetic nanoparticles can 
deliver the anticancer agent or drugs in the particular cancer 
site. It has potential applications such as in vivo drug 
delivery, biosensor, bio separation, magnetic storage, 
magnetic ink printing, microwave absorption, immune 
magnetic array, magnetic resonance imaging contrast agents 
and hyperthermia treatment of cancer3. Currently, various 
clinical trials are in progress to investigate the potential of 
different magnetic nano systems for pharmaceutical and 
biomedical applications. Appropriate precursors such as 
ferric chloride can be used for the reduction of plant 
extracts2. Iron oxide nanoparticle has the ability to kill the 
cells by two mechanisms. One is by target delivery of cancer 
drug in the cancer site and other by incorporating the heat to 
kill the cancer cells. 
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Syzygium aromaticum (Cloves) was the aromatic dried 
flower buds of a tree. Eugenol was the major compound 
present in the cloves. The anti oxidative, cytotoxic and 
genotoxic effects of eugenol and borneol has been tested and 
the study reveals that it has the ability to modulate 
resistance against the damaging effects of hydrogen 
peroxide on DNA of different strains of human cells4. 
Syzygium aromaticum was chosen to synthesize the iron 
oxide nanoparticles mainly for its anticancer activity5. It is 
used as a carminative to increase hydrochloric acid in the 
stomach and to improve peristalsis6. Besides acting as an 
antioxidant, cloves also possess many other functions, such 
as anti-inflammatory, antibacterial and antiseptic which 
make them an ideal natural source to be developed as an 
anticancer agent. Cloves have anti-carcinogenic properties, 
which have been proven to be helpful in controlling lung 
cancer when it is in the early stages. The scientists have 
found that cloves inhibit abnormal cell growth in lungs of 
mice7.  
Bee venom contains a complex mixture of proteins such as 
melittin, apamin, adolpin and phospholipase A2. Melittin has 
the potential to induce cytotoxic, antitumor, immune 
modulatory and apoptotic effects in different tumor cells in 
vivo or in vitro8. By specifically targeting the bee venom in 
the cancer site it can kill most of the cancer cells. Bee venom 
has been used for centuries in traditional medicine to relieve 
pain and treat chronic inflammatory diseases9. It has also 
been used in conditions such as arthritis, rheumatism and 
skin diseases. Melittin is the main component of bee venom 
and it is a biologically active peptide which constitutes about 
50% of bee venom’s dry weight10. The cytotoxicity of 
Melittin has been previously attributed to both necrotic and 
apoptotic cell death11. The MEL has cytotoxicity against cell 
lines like HeLa, WiDr and Vero. The MEL present in the bee 
venom was a promising anticancer agent12. The present 
study deals with the enhancement of anti-cancer activity of 
honey bee (Cerana indica) venom by mixing iron oxide 
nanoparticles synthesised from the extracts of Syzygium 
aromaticum against lung cancer cell line. 
MATERIALS AND METHODS 
 Sample collection: 
The buds of Syzygium aromaticum (25g) was purchased 
from retail shop in Tiruchengode, Namakkal. The honey bee 
(Cerana indica) venom was collected from EFGC Biological 
farm office, Sembakkam, Chennai. The A549 cell (Adeno 
carcinomic human alveolar basal epithelial cell) was 
purchased from King Institute of Preventive Medicine and 
Research, ICMR, Chennai, India.  
Preparation of Syzygium aromaticum  extracts (Monalisa 
and Nayak, 2013): 
Syzygium aromaticum buds were washed to remove dust 
particles and then shade dried and grinded into fine powder. 
The plant extract was prepared by mixing 5g of Syzygium 
aromaticum powder in 100 mL of distilled water. Then the 
solution is heated at 70°C for 5 minutes. The supernatant 
was filtered by using Whatmann filter paper. The filtrate was 
stored at 4°C for further experiments. 
 Synthesis of iron oxide nanoparticles from Syzygium 
aromaticum extracts: 
The iron oxide nanoparticles were synthesized by mixing the 
Syzygium aromaticum extract with 10 mM ferric chloride 
substrate12. About 1:10 ratio of Syzygium aromaticum 
extract and 10mM ferric chloride was prepared and heated 
at 70°C for 5 minutes. It was then incubated at room 
temperature for synthesis of iron oxide nanoparticles. 
Total phenolic content and Antioxidant assay of aqueous 
extract of Syzygium aromaticum and iron oxide 
nanoparticles: 
The total phenolic content of the Syzygium aromaticum 
extract and the sample of synthesized iron oxide 
nanoparticles were determined. The antioxidant activity of 
the synthesized iron oxide nanoparticles were determined 
by DPPH assay13.  
Characterization of iron oxide nanoparticles: 
The sample prepared for the synthesis of iron-oxide 
nanoparticles were characterized by UV-Visible Spectral 
analysis14, SEM (Scanning electron microscope) analysis12 
and EDS (Energy Disperse Spectroscopic analysis) analysis15, 
FT-IR (Fourier transform infra-red) analysis12 and XRD (X-
ray Diffraction) analysis16. Particle size of the iron oxide 
nanoparticle was determined by using Particle size analyzer. 
The sample was analyzed for its size in its liquid form. The 
lyophilized sample was dissolved in distilled water and it 
was analyzed. The sample was analyzed under the intensity 
of laser light on the sample particle. 
Protein estimation of bee venom: 
The protein present in the honey bee venom was 
estimated17. The amount of protein present in the bee 
venom was identified using standard graph. Bee venom 
contains a mixture of proteins in Melittin accounts for about 
52% of venom peptides. 
 Mixing of synthesized iron oxide nanoparticles with bee 
venom in various ratios: 
The synthesized iron oxide nanoparticles were mixed with 
bee venom to enhance the anticancer activity. The iron oxide 
nanoparticles and bee venom was mixed in the volume ratio 
of 1:1, 1:2, 1:3, 1:4 and 1:5. The samples containing different 
composition of synthesized iron-oxide nanoparticles and the 
bee venom were labelled properly. 
Identification of potential mixture of iron oxide 
nanoparticles and bee venom: 
The potential sample in the different mixture was identified 
by different assays. The potential sample was identified 
based on its anti-oxidant property. The DPPH (Diphenyl 
picryl hydrazyl) assay was done to identify the potential 
mixture18. Based on the inhibitory concentration of the 
different mixture in the above assay were used for the 
identification of potential composition. 
 DPPH assay of various ratios of iron oxide nanoparticles 
and bee venom: 
The DPPH (diphenyl picryl hydrazyl) assay was performed 
for various ratio of iron oxide nanoparticles and bee venom. 
The increasing concentration of ascorbic acid like 10, 20, 30, 
40 and 50µL was used as a standard. 10, 20, 30, 40 and 50µL 
of test samples were used to determine its antioxidant 
activity. The absorbance was obtained at 517 nm for each 
sample. The control was maintained to determine the 
inhibitory concentration of bee venom and the different 
ratio of iron oxide nanoparticles and bee venom. The 
inhibitory concentration was determined by the following 
formula. 
%inhibitory concentration=
          –         
         
     
Characterization of the potential mixture of iron oxide 
nanoparticles and bee venom: 
The interaction between the bee venom component and the 
synthesized iron oxide nanoparticles were studied by the 
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characterization studies. FT-IR (Fourier transform infrared 
spectroscopy) analysis was used to determine the functional 
groups present in the 1:1 ratio (potential mixture) of iron 
oxide nanoparticles and bee venom which has higher anti-
oxidant activity compared to other combinations. The 
chemical composition of the synthesized iron oxide 
nanoparticles was studied. The lyophilized sample powder 
was characterized in the range of 4000-400cm-1KBr pellet 
method. 
Anticancer activity of the potential mixture of iron oxide 
nanoparticles and bee venom: 
The anticancer activity of the potential composition and the 
bee venom was identified. The cytotoxicity tests were 
performed for potential mixture and bee venom. The 
cytotoxicity parameter like IC50 was calculated. It requires 
lung cancer cell line (A549) for the study.  
 Cell line and culture: 
Lung cancer cell line (A549) was cultured in Dulbecco’s 
modified Eagle’s medium (DMEM-Hi media lab, Mumbai, 
India) supplemented with 10% fetal bovine serum and 
maintained at 5% CO2   incubator. The anticancer activity of 
bee venom (Cerana indica) and potential mixture 1:1 ratio of 
iron oxide nanoparticles was studied by MTT assay11. 
Comparing the anticancer activity of bee venom and the 
1:1 ratio of iron oxide nanoparticles and bee venom: 
The anticancer activity of the potential combination and the 
bee venom by MTT assay were compared. By comparing 
these parameters the enhancement of the anticancer activity 
by the synthesized iron-oxide nanoparticles was identified. 
Statistical analysis: 
Values are represented as mean ± SD of three replicates. The 
data were statistically evaluated using GRAPHPAD PRISM 6 
software.  
RESULTS AND DISCUSSION 
Synthesis of iron oxide nanoparticles from extracts of 
Syzygium aromaticum, Total Phenolic content and 
antioxidant activity: 
The iron oxide nanoparticles were synthesized using 
Syzygium aromaticum extract and 10mM ferric chloride as a 
substrate. The total phenolic content of iron oxide 
nanoparticles and aqueous extract of Syzygium aromaticum 
were determined. It was increased with increasing 
concentration of extract. It was determined using the 
standard curve equation y=0.0095x-0.0057 with the R2value 
of 0.9803 (Fig. 1(a)). Iron oxide nanoparticles with the size 
of 33nm using ferric chloride as a substrate have been 
reported12 synthesized Iron oxide nanoparticles were 




Figure 1:   Analysis of Syzygium aromaticum extract 
(a) Total Phenolic content (b) DPPH assay of iron oxide nanoparticles 
 
The total phenolic content of the synthesized iron oxide 
nanoparticles were increased with increasing concentration 
of the aqueous extract (Fig. 1a). Studies of total phenolic 
content and total flavonoid content present in the selected 
medicinal plants contributed to the antioxidant activity 
which in turn aid in anticancer activity was reported18. 
Studies revealed that the biological activities of cloves 
(Syzygium aromaticum) represented the major sources of 
phenolic compounds 5. 
The DPPH assay was performed for iron oxide nanoparticles. 
The percentage inhibition was found to be increasing with 
increase in the concentration of the samples. The sample 
synthesized using 10mM as a substrate had higher 
antioxidant activity (Fig. 1 (b)). The IC50 value of the sample 
was found to be 75.22 µg/mL. Iron oxide nanoparticles were 
synthesized via chemical and green route and have 
effectively compared with the synthesized iron oxide 
nanoparticles13. According to their research the green route 
showed more free radical scavenging activity than the 
chemically synthesized iron oxide nanoparticles. The UV 
visible spectral analysis of iron oxide nanoparticles revealed 
that the maximum absorption was at 240nm, which 
indicated the reduction of metal ions to iron oxide 
nanoparticles (Fig. 2). This might be due to the excitation of 
surface plasmon vibrations of iron oxide nanoparticles. 
Reports are available on iron oxide nanoparticles which had 
the absorption peaks at 216-268 nm regions6. It confirmed 
the synthesis of iron oxide nanoparticles.  The characteristic 
surface plasmon absorption band at 233nm for synthesized 
magnetite nanoparticles was observed 14. 
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Figure 2:  Characterization of nanoparticles synthesized 
from Syzygium aromaticum - UV-Visible analysis  
 
 
Characterization of iron oxide nanoparticles: 
The SEM analysis was done for the iron oxide nanoparticles 
which had antioxidant activity. The particles were 
agglomerated at low magnification (2k) which indicated that 
the size and morphology was irregular (Fig.3a). The 
magnification of 25k x 17,000 the iron oxide nanoparticles 
from Annona squamosa  leaf were spherical structure was 
reported20. The SEM images of iron oxide nanoparticles were 
found to be aggregated, irregular sphere shapes with rough 
surfaces21. 
The elemental composition of the synthesized iron oxide 
nanoparticles which have anti-oxidant activity was done by 
Energy Disperse Spectroscopic (EDS) or Energy Disperse 
Analysis of X-rays (EDAX). The EDAX spectrum (Fig. 3b) 
shows iron, oxygen, chloride and sulphate signals. The 
chloride and the sulphate signals were mainly due to the 
substrate (ferric chloride and ferrous sulphate) used for the 
synthesis of iron oxide nanoparticles. EDS analysis of iron 
oxide nanoparticles with iron and oxygen peaks and 
reported the successful synthesis of magnetite (iron oxide) 
nanoparticles by green method using Caricaya papaya leaves 
12. Studies were carried out to optimized microwave assisted 
green synthesis protocol for iron oxide nanoparticles and 
studied the elemental composition of synthesized iron oxide 
nanoparticles using EDS 3. 
 
Figure 3: Characterization of nanoparticles synthesized from Syzygium aromaticum (a & b)-SEM analysis (c) EDS analysis (d) 
FT-IR spectrum 
 
FT-IR analysis was done to determine the functional groups 
present in the sample containing iron oxide nanoparticles. 
The chemical constituents in the solution containing 10mM 
ferric chloride and Syzygium aromaticum extract was 
revealed by FT-IR analysis. The peak at 3451.76 cm-1 
corresponds to the OH stretching of the alcohol and phenol. 
The signals at 2099.61 cm-1 indicates the presence of 
aliphatic C-H stretching in methylene groups. The signal at 
1639.56 cm-1 was due the stretching vibration of CO groups 
in ketones, aldehydes and carboxylic acids (Fig. 3c).  The 
synthesis of iron oxide nanoparticles was characterized by 
the absorption band at 467.76 cm-1, which corresponds to 
the Fe-O band. FT-IR analysis confirmed the reduction of 
ferric chloride into iron oxide nanoparticles. The FT-IR 
spectrum of Syzygium aromaticum extract which showed 
peaks at 3375cm-1, 2920-2852cm-1, 1730cm-1, 1643cm-1, 
1452cm-1and 1070cm-1 21. The absorption band at 467.76cm-
1 was absent in the spectrum of Syzygium aromaticum 
extract which indicated the presence of iron oxide 
nanoparticles. The ferric ions were reduced to iron oxide 
nanoparticles by the component present in the Syzygium 
aromaticum extract which act as a capping material. 
XRD analysis was performed to confirm the crystal structure 
of the synthesized iron oxide nanoparticles. The XRD 
spectrum of synthesized iron oxide nanoparticles was 
shown in the picture (Fig. 4a). The peaks at 2θ = 30.20˚, 
38.35˚, 44.48˚, 51.55˚, 64.15˚ and 82.55˚ were attributed to 
the crystal planes of iron oxide nanoparticles at 122, 004, 
140, 115, 312 and 343 respectively. The particle size was 
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analyzed using particle size analyzer. The average particle 
size distribution of the synthesized iron oxide nanoparticles 
was found to be 10-170 nm (Fig. 4b).The average particle 
size of the synthesized iron oxide nanoparticles was 
determined by taking the average of the sizes at the peaks 
and was found to be 52nm. The average particle size 
distribution of the iron oxide magnetic nanoparticles was 
found to be 30-80 nm 23. The particle size distribution of 
zero valent iron nanoparticles to be 52-120 nm. Average size 
of the iron oxide nanoparticle synthesized Psoralea 
corylifolia seed extract as 39nm 24 &19. 
 
 
Figure 4: Characterization of nanoparticles synthesized from Syzygium aromaticum 
(a) XRD analysis              (b) Particle size analysis 
Total protein estimation of bee venom: 
The total protein content present in the bee venom was 
estimated. The bee venom was taken in the concentration of 
20, 40, 60, 80 and 100µg/mL. The total protein in the bee 
venom was found to be 19.34, 29.057, 51.057, 73.91 and 
75.91µg/mL respectively. The total protein present in the 
venom sac of the three different Apis species was reported25. 
According to their report Apisdorsata has higher amount of 
protein than Apismellifera and Apisflorea.  
Mixing of synthesized iron oxide nanoparticles with bee 
venom: 
The iron oxide nanoparticles having higher antioxidant 
activity and the bee venom was mixed in various volume 
ratio of 1:1, 1:2, 1:3, 1:4 and 1:5.  
Antioxidant activity of bee venom: 
DPPH assay was done to determine the antioxidant property 
of the bee venom. The antioxidant assay of bee venom 
increases with increase in concentration of 20, 30, 40 and 
50µg/mL. The highest % inhibition was found to be 34.84% 
which was obtained at 50µg/mL. The IC50 value of the bee 
venom was found to be 65.5325µg/mL. In the antioxidant 
activity of the 1:1 ratio of iron oxide nanoparticles and bee 
venom the % inhibition at the concentration of 50µg/mL 
was found to be 46.46. The IC50 value of the sample 
containing 1:1 ratio of iron oxide nanoparticles and bee 
venom was found to be 55.9493µg/mL. The 1:2 ratio of iron 
oxide nanoparticle and bee venom showed less antioxidant 
activity than 1:1 ratio of iron oxide nanoparticles and bee 
venom. The % inhibitory concentration at 50µg/mL was 
found to be 30.3. The IC50 value was found to be 
1.4223µg/mL. The antioxidant activity of the 1:3 ratio of 
iron oxide nanoparticles and bee venom was less than the 
1:1 and 1:2 ratios. The % inhibitory concentration at 
50µg/mL was found to be 24.74. The IC50 value of the 1:3 
ratio of iron oxide nanoparticles and bee venom was found 
to be 94.6256µg/mL.  Similar kind of mixture of 
nanoparticle with venom was carried out26. They have 
created biodegradable chitosan nanoparticles for loading 
Naja najaoxiana cobra venom and evaluated their (chitosan 
nanoparticles containing snake venom) potential as antigen 
delivery systems. The highest % inhibition was found to be 
34.84% which was obtained at 50µg/mL. The IC50 value of 
the bee venom was found to be 65.5325µg/mL.. 
 
 
Figure 5: Analysis of 1:1 ratio of Iron oxide nanoparticles and bee venom 
(a) Per centage inhibition of A549 cells (b) Cytotoxicity activity 
All the data represented in the figure are the average of three replicates 
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FT-IR analysis of the potential mixture of iron oxide 
nanoparticles and bee venom: 
The functional group present in the 1:1 ratio of iron oxide 
nanoparticles and bee venom was identified by FT-IR 
analysis. The peak obtained at 3451.76 cm-1 indicated the 
presence of O-H alcohol stretching and H-bonded. The peak 
at 2075.5 cm-1 represents the presence of aliphatic C-H 
stretching in methylene groups. The sharp peaks at 
indicated the aromatic attached to the functional groups of 
C=N, C=C and NH stretching by multiple combination. The 
absorption peak at 467.76 cm-1 corresponds to the Fe-O 
band. 
 
Figure 6: Concentration dependent proliferation of the 
A549 cell lines 
(a) Control (b) 25µg/mL  (c) 100µg/mL (d) 250µg/mL 
Anticancer activity of 1:1 ratio of iron oxide 
nanoparticles and bee venom:  
The MTT assay was performed to determine the cytotoxicity 
of the 1:1 ratio of iron oxide nanoparticles and bee venom in 
which the sample was taken at different concentrations and 
treated against A549 cells (Adeno carcinomic human 
alveolar basal epithelial cells). The morphological changes 
were observed in the cells after the treatment with 1:1 ratio 
of iron oxide nanoparticles and bee venom. The percentage 
inhibition of A549 cells was determined at different 
concentrations. The percentage inhibition was found to be 
57.63% at 250µg/mL (Fig.5a & b). The MTT assay of 1:1 
ratio of iron oxide nanoparticles and bee venom was studied. 
The percentage inhibition of A549 cells (Adeno carcinomic 
human alveolar basal epithelial cells) at various 
concentrations of the sample at 4 hours incubation was 
studied. The percentage inhibition at 25µg/mL was found to 
be 17.74% with the 4 hours of treatment and it was 
observed with the morphological changes which was clearly 
visible (Fig.6b). At 50µg/mL, inhibition was 35.49% At 
100µg/mL, it was 45.04% and the morphological changes 
were observed (Fig. 6c). At 250µg/mL, the percentage 
inhibition was found to be 57.63% and it was near to the IC50 
value (Fig. 6 d). At 500µg/mL, inhibition was found to be 
62.40% and the morphological changes were observed. The 
Fig. 6 (a) represents the control. Our results were correlated 
with the study of honey bee venom and Zingiber officinale 
extract had more cytotoxicity against breast adeno 
carcinoma cells (MCF-7) was reported27 . 
Cytotoxicity of bee venom against lung cancer cell line 
proved that bee venom induced cytotoxicity at the 
concentration of 10µg/mL and it exhibited cell shrinkage, 
cytoplasmic condensation and irregularity in shape after 24 
hours of treatment28. The presence of iron oxide 
nanoparticles with the bee venom in the volume ratio 1:1 
induces cell death in lung cancer cell line within 4 hours of 
treatment and this indicated that the iron oxide 
nanoparticles synthesized using Syzygium aromaticum have 
enhanced the anticancer activity of bee venom. 
CONCLUSION 
The iron oxide nanoparticles were synthesized from the 
extracts of Syzygium aromaticum. The iron oxide 
nanoparticles were mixed with various ratios of bee venom 
and the activity was identified by DPPH assay. In MTT assay 
of the 1:1 volume ratio of iron oxide nanoaprticles and bee 
venom was found to have higher cytotoxicity against lung 
cancer cell line. It confirms the progress of anticancer 
activity of bee venom by iron oxide nanoparticles 
synthesized using Syzygium aromaticum extract. This study 
contributes to novel materials as alternative therapeutic 
treatment for human lung cancer cell line. Hence, further 
studies are needed to identify the mechanisms of anticancer 
activity and toxicity of this mixture. 
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